Zinzino Q1 Preliminary Sales Report: 26% Increase

April 3, 2026
Press Release

Zinzino AB (publ) (ZZ-B.ST) group revenue increased with a total of 26 % in Q1 compared with the previous year.

GOTHENBURG, Sweden – The revenue in March 2026 for Zinzino‘s sales markets increased by 29% and amounted to SEK 342.2 (265.8) million. [Approx. USD $36.3 million]

Faun Pharma’s external sales decreased and amounted to SEK 6.6 (7.1) million. Overall, the Group increased revenues by 28% to SEK 348.8 (272.9) million compared with the previous year.

Q1 Group Revenue:

The group revenue increased with 26% for Q1 2026 compared with the first quarter last year and amounted to SEK 915.4 (723.7) million. [Approx. USD $97 million]

Revenues were distributed as follows:

Regions, mSEK	26-March	25-March	Change	Q1 2026	Q1 2025	Change
The Nordics	27.1	26.6	2%	77.7	77.1	1%
Central Europe	103.3	69.6	48%	274.9	196.4	40%
East Europe	29.5	34.0	-13%	85.1	97.2	-12%
South & West Europe	59.2	42.9	38%	155.7	124.9	25%
The Baltics	10.3	9.4	10%	29.2	28.7	2%
North America	80.2	56.1	43%	188.7	110.3	71%
South America	4.3	0.6	617%	11.8	2.3	413%
Asia-Pacific	25.9	24.6	5%	66.8	65.8	2%
Africa	2.4	2.0	20%	6.5	5.0	30%
Zinzino	342.2	265.8	29%	896.4	707.7	27%
Faun Pharma	6.6	7.1	-7%	19.0	16.0	19%
Zinzino Group	348.8	272.9	28%	915.4	723.7	26%

Countries in Regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
South America: Peru, Colombia
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

About Zinzino

Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.

Zinzino’s scientifically proven nutritional supplements are available in more than 100 markets across the world. Zinzino has acquired all assets in the health and wellness companies It Works!, Enhanzz Global, Truvy, Bodē Pro, Valentus, Zurvita and Xelliss, and Sanki Global. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters are in Gothenburg, Sweden, with additional offices in Europe, Asia, and Australia. For more information, please visit www.zinzino.com

Source: Zinzino

Get more information, facts and figures about Zinzino, click here for the Zinzino overview.

Disclaimer: At BFH, we strive to keep all content—articles, press releases, data—as accurate and current as possible at time of publishing. However, treat this content as a guide, not as definitive authority for business decisions. Publishing a press release does not imply Business For Home BV endorses a company or individual, nor guarantees its claims. No warranties or representations, expressed or implied, are made regarding the accuracy, completeness, or suitability of information provided on this website. All content is provided “as-is,” without liability for errors or usage. Always fact-check and conduct your own due diligence. BFH publishes press releases for the global Direct Selling / Network Marketing / Home Business community. Laws governing Direct Selling can vary greatly by country; BFH does not warrant that any company or content is in full compliance with various local or country-specific laws; it’s up to the reader to research, verify and comply with all applicable local regulations.

Scott Simons